U.S. market Open. Closes in 5 hours 28 minutes

DGX | Quest Diagnostics Incorporated Stock Overview

(Stock Exchange: NYSE)
Day's Range 167.48 - 170.64
52 Week Range 125.42 - 178.87
Beta 0.75
Implied Volatility 28.38%
IV Rank 63.44%
Day's Volume 1,148,846
Average Volume 1,104,983
Shares Outstanding 110,978,000
Market Cap 18,777,477,600
Sector Healthcare
Industry Medical - Diagnostics & Research
IPO Date 1996-12-17
Valuation
Profitability
Growth
Health
P/E Ratio 21.97
Forward P/E Ratio 14.71
EPS 7.70
1YR Price Target 154.00
Dividend Yield 1.91%
Dividend Per Share 2.12
Dividend ExDate 2023-01-17
Dividend PayDate 2023-02-01
Employees 50,000
Country USA
Website DGX
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
DGX's peers: IQV, MTD, TWST, WAT, ICLR, IDXX, CRL, RVTY, SHC, A, LH
*Chart delayed
Analyzing fundamentals for DGX we got that it has average fundamentals where Valuation is considered to be undervalued, Profitability is poor, Growth is good and Health is passable. For more detailed analysis please see DGX Fundamentals page.

Watching at DGX technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on DGX Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙